Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (30)
M.A. Trishchynska & V.M. Dubynetska. (2023) Neural amyotrophy of Charcot-Marie-Tooth (clinical case). INTERNATIONAL NEUROLOGICAL JOURNAL 19:6, pages 184-190.
Crossref
Crossref
Nicholas J. Maragakis, Mamede de Carvalho & Michael D. Weiss. (2023)
Therapeutic targeting of
ALS
pathways: Refocusing an incomplete picture
. Annals of Clinical and Translational Neurology 10:11, pages 1948-1971.
Crossref
Crossref
Fulya Akçimen, Elia R. Lopez, John E. Landers, Avindra Nath, Adriano Chiò, Ruth Chia & Bryan J. Traynor. (2023) Amyotrophic lateral sclerosis: translating genetic discoveries into therapies. Nature Reviews Genetics 24:9, pages 642-658.
Crossref
Crossref
Wesley M. Stansberry & Brian A. Pierchala. (2023) Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis. Frontiers in Molecular Neuroscience 16.
Crossref
Crossref
Barış Genç, Boram Nho, Hana Seung, Benjamin Helmold, Huiwon Park, Öge Gözütok, Seunghyun Kim, Jinil Park, Sanghyun Ye, Haneul Lee, Nayeon Lee, Seung-Shin Yu, Sunyoung Kim, Junghun Lee & Hande Özdinler. (2023) Novel rAAV vector mediated intrathecal HGF delivery has an impact on neuroimmune modulation in the ALS motor cortex with TDP-43 pathology. Gene Therapy 30:7-8, pages 560-574.
Crossref
Crossref
Yuji Okamoto & Hiroshi Takashima. (2023) The Current State of Charcot–Marie–Tooth Disease Treatment. Genes 14:7, pages 1391.
Crossref
Crossref
Marina Stavrou, Alexia Kagiava, Irene Sargiannidou, Elena Georgiou & Kleopas A. Kleopa. (2023)
Charcot–Marie–Tooth
neuropathies: Current gene therapy advances and the route toward translation
. Journal of the Peripheral Nervous System 28:2, pages 150-168.
Crossref
Crossref
Shengzhou Shan, Qingfeng Li, Tracy Criswell, Anthony Atala & Yuanyuan Zhang. (2023) Stem cell therapy combined with controlled release of growth factors for the treatment of sphincter dysfunction. Cell & Bioscience 13:1.
Crossref
Crossref
Zeynep YILDIRIM, Dicle Naz TOKTAŞ, Öznur DEMİR, Zülfiye GÜL & Burcu ŞEN UTSUKARÇİ. (2023) Amyotrofik Lateral Skleroz Patofizyolojisi ve Tedavi YaklaşımlarıAn Evaluation of Amyotrophic Lateral Sclerosis and Current Situation in Its Treatment. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
Crossref
Marina Stavrou & KleopasA Kleopa. (2023) CMT1A current gene therapy approaches and promising biomarkers. Neural Regeneration Research 18:7, pages 1434.
Crossref
Crossref
Ann Logan, Antonio Belli, Valentina Di Pietro, Barbara Tavazzi, Giacomo Lazzarino, Renata Mangione, Giuseppe Lazzarino, Inés Morano, Omar Qureshi, Lars Bruce, Nicholas M. Barnes & Zsuzsanna Nagy. (2022) The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate: New platform therapy for neurodegenerative diseases like Amyotrophic Lateral Sclerosis. Frontiers in Pharmacology 13.
Crossref
Crossref
Ann Logan, Zsuzsanna Nagy, Nicholas M. Barnes, Antonio Belli, Valentina Di Pietro, Barbara Tavazzi, Giuseppe Lazzarino, Giacomo Lazzarino, Lars Bruce & Lennart I. Persson. (2022) A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis. PLOS ONE 17:5, pages e0267183.
Crossref
Crossref
Devan L. Puhl, Divya Mohanraj, Derek W. Nelson & Ryan J. Gilbert. (2022) Designing electrospun fiber platforms for efficient delivery of genetic material and genome editing tools. Advanced Drug Delivery Reviews 183, pages 114161.
Crossref
Crossref
Megan Dubowsky, Stephanie R Shepheard & Mary-Louise Rogers. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1893
1929
.
Megan Dubowsky, Stephanie R Shepheard & Mary-Louise Rogers. 2021. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1
37
.
Claudia Desole, Simona Gallo, Annapia Vitacolonna, Francesca Montarolo, Antonio Bertolotto, Denis Vivien, Paolo Comoglio & Tiziana Crepaldi. (2021) HGF and MET: From Brain Development to Neurological Disorders. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Marina Stavrou, Irene Sargiannidou, Elena Georgiou, Alexia Kagiava & Kleopas A. Kleopa. (2021) Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies. International Journal of Molecular Sciences 22:11, pages 6048.
Crossref
Crossref
John A. Kessler, Aziz Shaibani, Christine N. Sang, Mark Christiansen, David Kudrow, Aaron Vinik & Nari Shin. (2021) Gene therapy for diabetic peripheral neuropathy: A randomized, placebo‐controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor. Clinical and Translational Science 14:3, pages 1176-1184.
Crossref
Crossref
Maurits F. J. M. Vissers, Jules A. A. C. Heuberger & Geert Jan Groeneveld. (2021) Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders. International Journal of Molecular Sciences 22:4, pages 1615.
Crossref
Crossref
Antonio Vallarola, Massimo Tortarolo, Roberta De Gioia, Luisa Iamele, Hugo de Jonge, Giovanni de Nola, Enrica Bovio, Laura Pasetto, Valentina Bonetto, Mattia Freschi, Caterina Bendotti & Ermanno Gherardi. (2020) A Novel HGF/SF Receptor (MET) Agonist Transiently Delays the Disease Progression in an Amyotrophic Lateral Sclerosis Mouse Model by Promoting Neuronal Survival and Dampening the Immune Dysregulation. International Journal of Molecular Sciences 21:22, pages 8542.
Crossref
Crossref
Tomoya Terashima, Shuhei Kobashi, Yasuhiro Watanabe, Mami Nakanishi, Naoto Honda, Miwako Katagi, Natsuko Ohashi & Hideto Kojima. (2020) Enhancing the Therapeutic Efficacy of Bone Marrow-Derived Mononuclear Cells with Growth Factor-Expressing Mesenchymal Stem Cells for ALS in Mice. iScience 23:11, pages 101764.
Crossref
Crossref
Michal Izrael, Shalom Guy Slutsky & Michel Revel. (2020) Rising Stars: Astrocytes as a Therapeutic Target for ALS Disease. Frontiers in Neuroscience 14.
Crossref
Crossref
Heike J. Wobst, Korrie L. Mack, Dean G. Brown, Nicholas J. Brandon & James Shorter. (2020) The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future. Medicinal Research Reviews 40:4, pages 1352-1384.
Crossref
Crossref
Tereza Filipi, Zuzana Hermanova, Jana Tureckova, Ondrej Vanatko & Miroslava Anderova. (2020) Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment. Journal of Clinical Medicine 9:1, pages 261.
Crossref
Crossref
Sang Hwan Lee, Subin Kim, Nayeon Lee, Junghun Lee, Seung Shin Yu, Jin Hong Kim & Sunyoung Kim. (2019) Intrathecal delivery of recombinant AAV1 encoding hepatocyte growth factor improves motor functions and protects neuromuscular system in the nerve crush and SOD1-G93A transgenic mouse models. Acta Neuropathologica Communications 7:1.
Crossref
Crossref
Frederick L. Hitti, Andrew I. Yang, Pedro Gonzalez-Alegre & Gordon H. Baltuch. (2019) Human gene therapy approaches for the treatment of Parkinson's disease: An overview of current and completed clinical trials. Parkinsonism & Related Disorders 66, pages 16-24.
Crossref
Crossref
Boram Nho, Junghun Lee, Junsub Lee, Kyeong Ryang Ko, Sung Joong Lee & Sunyoung Kim. (2018) Effective control of neuropathic pain by transient expression of hepatocyte growth factor in a mouse chronic constriction injury model. The FASEB Journal 32:9, pages 5119-5131.
Crossref
Crossref
Shigeru Hirano, Atsuhiko Kawamoto, Ichiro Tateya, Masanobu Mizuta, Yo Kishimoto, Nao Hiwatashi, Yoshitaka Kawai, Takuya Tsuji, Ryo Suzuki, Mami Kaneko, Yasushi Naito, Tatsuo Kagimura, Tatsuo Nakamura & Shin‐ichi Kanemaru. (2017) A phase I/II exploratory clinical trial for intracordal injection of recombinant hepatocyte growth factor for vocal fold scar and sulcus. Journal of Tissue Engineering and Regenerative Medicine 12:4, pages 1031-1038.
Crossref
Crossref
Andrew P. Tosolini & James N. Sleigh. (2017) Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 10.
Crossref
Crossref
Jayanth S. Chandran, Joseph M. Scarrott, Pamela J. Shaw & Mimoun Azzouz. 2017. Personalised Medicine. Personalised Medicine
241
257
.